[go: up one dir, main page]

SK37695A3 - Rein inhibiting n-(2-amino-2-oxoethyl) butanediamine derivatives - Google Patents

Rein inhibiting n-(2-amino-2-oxoethyl) butanediamine derivatives Download PDF

Info

Publication number
SK37695A3
SK37695A3 SK376-95A SK37695A SK37695A3 SK 37695 A3 SK37695 A3 SK 37695A3 SK 37695 A SK37695 A SK 37695A SK 37695 A3 SK37695 A3 SK 37695A3
Authority
SK
Slovakia
Prior art keywords
methyl
cyclohexylmethyl
amino
oxoethyl
dihydroxy
Prior art date
Application number
SK376-95A
Other languages
English (en)
Slovak (sk)
Inventor
Pierre Lavallee
Bruno Simoneau
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of SK37695A3 publication Critical patent/SK37695A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SK376-95A 1992-09-25 1993-09-15 Rein inhibiting n-(2-amino-2-oxoethyl) butanediamine derivatives SK37695A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95147892A 1992-09-25 1992-09-25
PCT/CA1993/000380 WO1994007846A1 (en) 1992-09-25 1993-09-15 Renin inhibiting n-(2-amino-2-oxoethyl)butanediamide derivatives

Publications (1)

Publication Number Publication Date
SK37695A3 true SK37695A3 (en) 1995-07-11

Family

ID=25491725

Family Applications (1)

Application Number Title Priority Date Filing Date
SK376-95A SK37695A3 (en) 1992-09-25 1993-09-15 Rein inhibiting n-(2-amino-2-oxoethyl) butanediamine derivatives

Country Status (29)

Country Link
US (2) US5541163A (et)
EP (1) EP0589445B1 (et)
JP (1) JP3490442B2 (et)
KR (1) KR950703520A (et)
CN (1) CN1090278A (et)
AT (1) ATE147720T1 (et)
AU (1) AU680829B2 (et)
BG (1) BG99542A (et)
BR (1) BR9307110A (et)
CA (1) CA2143300C (et)
CO (1) CO4560549A1 (et)
CZ (1) CZ74895A3 (et)
DE (1) DE69307446T2 (et)
EE (1) EE03083B1 (et)
FI (1) FI951398L (et)
HU (2) HUT70432A (et)
IL (1) IL107092A (et)
LT (1) LT3072B (et)
LV (1) LV10945B (et)
MX (1) MX9305918A (et)
NO (1) NO951133L (et)
NZ (1) NZ255301A (et)
PH (1) PH30881A (et)
PL (1) PL174454B1 (et)
RU (1) RU95113586A (et)
SK (1) SK37695A3 (et)
TW (1) TW239117B (et)
WO (1) WO1994007846A1 (et)
ZA (1) ZA937079B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007845A1 (en) * 1992-09-25 1994-04-14 Bio-Mega/Boehringer Ingelheim Research Inc. N-(hydroxyethyl)butanediamide derivatives as renin inhibitors
CA2165996C (en) * 1995-12-22 2002-01-29 Murray Douglas Bailey Stereoselective preparation of 2-substituted succinic derivatives
US6096759A (en) * 1997-09-19 2000-08-01 Georgetown University Method for treating essential hypertension
US20050209141A1 (en) * 2003-10-17 2005-09-22 Silver Randi B Mast cell-derived renin
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5142056A (en) 1989-05-23 1992-08-25 Abbott Laboratories Retroviral protease inhibiting compounds
US5006511A (en) * 1981-10-14 1991-04-09 Merck & Co., Inc. Di- or tripeptide renin inhibitors containing lactam conformational restriction in achpa
EP0278158A3 (en) 1986-11-12 1990-05-23 Merck & Co. Inc. Renin inhibitors containing phenylalanyl-histidine replacements
US4839357A (en) 1987-10-02 1989-06-13 Merck & Co., Inc. Renin inhibitors containing phenylalanyl-histidine replacements
EP0312283A3 (en) * 1987-10-14 1990-05-09 Merck & Co. Inc. Di-or tripeptide renin inhibitors containing lactam conformational restrictions in achpa
US5001113A (en) 1987-10-14 1991-03-19 Merck & Co., Inc. Di- or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives
FI893212L (fi) * 1988-07-01 1990-01-02 Searle & Co Antihypertensiva aminoalkylaminokarbo- nylaminodiolaminsyraderivat.
US5063208A (en) * 1989-07-26 1991-11-05 Abbott Laboratories Peptidyl aminodiol renin inhibitors
IE902446A1 (en) * 1989-07-26 1991-02-13 Abbott Lab Peptidyl aminodiol renin inhibitors
EP0417698B1 (de) * 1989-09-12 1996-03-13 Hoechst Aktiengesellschaft Aminosäurederivate mit reninhemmenden Eigenschaften, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung
JPH0532602A (ja) * 1991-07-26 1993-02-09 Terumo Corp ナフチルメチルアミン誘導体及びこれを含有するレニン阻害剤

Also Published As

Publication number Publication date
AU4940393A (en) 1994-04-26
ATE147720T1 (de) 1997-02-15
PL308180A1 (en) 1995-07-24
DE69307446T2 (de) 1997-05-15
HU211315A9 (en) 1995-11-28
NO951133D0 (no) 1995-03-24
WO1994007846A1 (en) 1994-04-14
CN1090278A (zh) 1994-08-03
HUT70432A (en) 1995-10-30
JP3490442B2 (ja) 2004-01-26
NZ255301A (en) 1997-05-26
TW239117B (et) 1995-01-21
BR9307110A (pt) 1999-03-30
AU680829B2 (en) 1997-08-14
MX9305918A (es) 1994-05-31
ZA937079B (en) 1994-06-06
LTIP1092A (en) 1994-05-15
BG99542A (bg) 1995-12-29
EP0589445B1 (en) 1997-01-15
US5541163A (en) 1996-07-30
RU95113586A (ru) 1997-01-10
CO4560549A1 (es) 1998-02-10
CA2143300A1 (en) 1994-04-14
CA2143300C (en) 1998-04-21
FI951398A7 (fi) 1995-03-24
NO951133L (no) 1995-05-24
DE69307446D1 (de) 1997-02-27
FI951398A0 (fi) 1995-03-24
FI951398L (fi) 1995-03-24
IL107092A0 (en) 1993-12-28
EE03083B1 (et) 1998-04-15
HU9500871D0 (en) 1995-05-29
CZ74895A3 (en) 1995-12-13
LT3072B (en) 1994-11-25
KR950703520A (ko) 1995-09-20
IL107092A (en) 1997-09-30
LV10945B (en) 1996-06-20
JPH08501567A (ja) 1996-02-20
LV10945A (lv) 1995-12-20
US5693619A (en) 1997-12-02
EP0589445A1 (en) 1994-03-30
PL174454B1 (pl) 1998-07-31
PH30881A (en) 1997-12-23

Similar Documents

Publication Publication Date Title
AU2002344820B2 (en) Dipeptidyl peptidase inhibitors for the treatment of diabetes
KR101634656B1 (ko) 피롤리딘 유도체
SK48499A3 (en) Heteroaryl succinamides and their use as metalloproteinase inhibitors
JP2628820B2 (ja) アミノ酸誘導体及びその医薬品としての利用
US5459131A (en) Renin inhibitors
SK37695A3 (en) Rein inhibiting n-(2-amino-2-oxoethyl) butanediamine derivatives
US5554634A (en) N-(hydroxyethyl)butanediamide derivatives
WO1992022313A1 (en) Renin inhibiting compounds